Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.
Elevated proinsulin secretion and islet amyloid deposition are both features of Type 2 diabetes but their relationship to beta-cell dysfunction is unknown. To determine if islet amyloid polypeptide (IAPP) secretion is disproportionate with other beta-cell products at any stage of glucose intolerance...
Autores principales: | MacNamara, C, Barrow, B, Manley, SE, Levy, J, Clark, A, Turner, R |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2000
|
Ejemplares similares
-
Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
por: Clark, A, et al.
Publicado: (1987) -
Autoantibodies to islet amyloid polypeptide in diabetes.
por: Clark, A, et al.
Publicado: (1991) -
Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis.
por: Esapa, C, et al.
Publicado: (2005) -
Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology
por: Rehana Akter, et al.
Publicado: (2016-01-01) -
Fibrillar dimer formation of islet amyloid polypeptides
por: Chi-cheng Chiu, et al.
Publicado: (2015-09-01)